Carrier testing in hemophilia B with an immunoassay that distinguishes a prevalent factor IX dimorphism.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Blood

• Publication date

  1987-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V70.4.1006.1006PMID 3651597
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Two allotypes of factor IX present in haemophilia B.

  2009cited by this paper
• Factor IXAlabama: a point mutation in a clotting protein results in hemophilia B.

  1987cited by this paper
• Factor IX metal ion-dependent antigen assays for measurement of warfarin effect.

  1987cited by this paper
• Defective propeptide processing of blood clotting factor IX caused by mutation of arginine to glutamine at position -4.

  1986cited by this paper
• Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.

  1986cited by this paper
• Structure, function, and molecular defects of factor IX.

  1986cited by this paper
• Diagnosis of haemophilia B carriers using intragenic oligonucleotide probes.

  1986cited by this paper
• Antigenic determinant in human coagulation factor IX: immunological screening and DNA sequence analysis of recombinant phage map a monoclonal antibody to residues 111 through 132 of the zymogen.

  1986cited by this paper
• Expression, purification, and characterization of recombinant gamma-carboxylated factor IX synthesized in Chinese hamster ovary cells.

  1986cited by this paper
• Calcium-specific immunoassays for factor IX: reduced levels of antigen in patients with vitamin K disorders.

  1986cited by this paper
• Molecular basis of hemophilia B: a defective enzyme due to an unprocessed propeptide is caused by a point mutation in the factor IX precursor.

  1986cited by this paper
• Haemophilia B caused by a point mutation in a donor splice junction of the human factor IX gene

  1985cited by this paper
• Proteolytic inactivation of blood coagulation factor IX by thrombin.

  1985cited by this paper
• Evidence for a prevalent dimorphism in the activation peptide of human coagulation factor IX.

  1985cited by this paper
• Active gamma-carboxylated human factor IX expressed using recombinant DNA techniques.

  1985cited by this paper
• Polymorphism of normal factor IX detected by mouse monoclonal antibodies.

  1985cited by this paper
• Expression of active human clotting factor IX from recombinant DNA clones in mammalian cells

  1985cited by this paper
• Active γ-carboxylated human factor IX expressed using recombinant DNA techniques

  1985cited by this paper
• Expression of active human factor IX in transfected cells

  1985cited by this paper
• Nucleotide sequence of the gene for human factor IX (antihemophilic factor B).

  1985cited by this paper
• Monoclonal antibodies to coagulation factor IX define a high-frequency polymorphism by immunoassays.

  1985cited by this paper
• An intragenic deletion of the factor IX gene in a family with hemophilia B.

  1985cited by this paper
• Coagulation Factor IX concentrate: method of preparation and assessment of potential in vivo thrombogenicity in animal models.

  1984cited by this paper
• Isolation and characterization of human factor IX cDNA: Identification of Taq I polymorphism and regional assignment

  1984cited by this paper
• Carrier detection by direct gene analysis in a family with haemophilia B (factor IX deficiency).

  1984cited by this paper
• Carrier detection in haemophilia B using two further intragenic restriction fragment length polymorphisms.

  1984cited by this paper
• Monoclonal antibodies to factor IX: characterization and use in immunoassays for factor IX.

  1984cited by this paper
• A RAPID SMALL-SCALE PROCEDURE FOR ISOLATION OF PHAGE LAMBDA DNA

  1984cited by this paper
• The gene structure of human anti‐haemophilic factor IX.

  1984cited by this paper
• A technique for specific removal of factor IX alloantibodies from human plasma: partial characterization of the alloantibodies

  1983cited by this paper
• Gene deletions in patients with haemophilia B and anti-factor IX antibodies

  1983cited by this paper
• Isolation of a human anti-haemophilic factor IX cDNA clone using a unique 52-base synthetic oligonucleotide probe deduced from the amino acid sequence of bovine factor IX.

  1983cited by this paper
• Monoclonal antibody to an epitope on the heavy chain of factor IX missing in three hemophilia-B patients.

  1983cited by this paper
• Identification of the molecular defect in factor IX Chapel Hill: substitution of histidine for arginine at position 145.

  1983cited by this paper
• Buffer gradient gels and 35S label as an aid to rapid DNA sequence determination.

  1983cited by this paper
• A technique for specific removal of factor IX alloantibodies from human plasma: partial characterization of the alloantibodies.

  1983cited by this paper
• Isolation and characterization of a cDNA coding for human factor IX.

  1982cited by this paper
• A system for shotgun DNA sequencing.

  1981cited by this paper
• Methods for the preparation of enzyme-antibody conjugates for use in enzyme immunoassay.

  1981cited by this paper
• Activation of human factor IX (Christmas factor).

  1978cited by this paper
• Factor IX antigen by radioimmunoassay in heterozygotes for hemophilia B.

  1977cited by this paper
• Hemophilia B: characterization of genetic variants and detection of carriers.

  1977cited by this paper
• [5] Molecular weight determination of glycoproteins by polyacrylamide gel electrophoresis in sodium dodecyl sulfate

  1972cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

  1969cited by this paper
• THE CONTACT PHASE OF BLOOD COAGULATION

  1965cited by this paper

• An introduction for clinicians

  2015cites this paper
• Allelic heterogeneity of molecular events in human coagulation factor IX in Asian Indians

  2007cites this paper
• Transgene expression levels and kinetics determine risk of humoral immune response modeled in factor IX knockout and missense mutant mice

  2007cites this paper
• Polymorphism of Factor IX : Establishing the Genotypes by Rapid Analysis of DNA By

  2005cites this paper
• Creation of a mouse expressing defective human factor IX.

  2004cites this paper
• Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.

  2004cites this paper
• Haemophilia A and haemophilia B: molecular insights

  2002cites this paper
• Detailed characterization of an anti-factor IX monoclonal antibody that neutralizes the prolonged ox brain prothrombin time of hemophilia B(M) by synthetic peptides.

  2000cites this paper
• Hemophilia B with Mutations at Glycine-48 of Factor IX Exhibited Delayed Activation by the Factor VIIa-tissue Factor Complex

  2000cites this paper
• Molekularbiologie und Genetik der Hämophilie B

  1999cites this paper
• Sensory gating deficits in parents of schizophrenics.

  1995cites this paper
• Hemoglobin F synthesis is not restricted to fetal erythropoietic organs during extramedullary hematopoiesis.

  1994cites this paper
• Characterization of a factor IX variant with a glycine207 to glutamic acid mutation.

  1994cites this paper
• High-affinity, specific factor IXa binding to platelets is mediated in part by residues 3-11.

  1994cites this paper
• A comparison of the allelic frequencies of ten DNA polymorphisms associated with factor VIII and factor IX genes in Thai and Western European populations

  1994cites this paper
• Mechanisms of thrombin generation during surgery and cardiopulmonary bypass.

  1993cites this paper
• Genetic Basis and Carrier Detection of Hemophilia B of Chinese Origin

  1993cites this paper
• Carrier detection in the haemophilias

  1992cites this paper
• Characterization of Genetic Defects of Hemophilia B of Chinese Origin

  1991cites this paper
• Population genetics of the Malmö polymorphism of coagulation factor IX.

  1991cites this paper
• Expression and characterization of human factor IX and factor IX-factor X chimeras in mouse C127 cells.

  1990cites this paper
• Functionally important regions of the factor IX gene have a low rate of polymorphism and a high rate of mutation in the dinucleotide CpG.

  1989cites this paper
• The Malmö polymorphism of factor IX: establishing the genotypes by rapid analysis of DNA.

  1989cites this paper
• A moderate form of hemophilia B is caused by a novel mutation in the protease domain of factor IXVancouver.

  1989cites this paper
• Three point mutations in the factor IX genes of five hemophilia B patients. Identification strategy using localization by altered epitopes in their hemophilic proteins.

  1989cites this paper
• The Use of DNA Amplification for Genetic Counselling Related Diagnosis in Haemophilia B

  1989cites this paper
• Diagnostic role of an immunoassay-detected polymorphism of factor IX for potential carriers of hemophilia B.

  1988cites this paper
• Immunoaffinity purification of factor IX from commercial concentrates and infusion studies in animals.

  1988cites this paper
• The Malmö polymorphism of coagulation factor IX, an immunologic polymorphism due to dimorphism of residue 148 that is in linkage disequilibrium with two other F.IX polymorphisms.

  1988cites this paper
• MAPPING OF 6 MONOCLONAL ANTIBODIES TO HUMAN FACTOR IX

  1987cites this paper